Summary of 615 patients of chronic myeloid leukemia in Shanghai from 2001 to 2006

Posted by rob on March 5, 2010 under Uncategorized | Comments are off for this article

Conclusions:
The number of new patients arising in Shanghai increased from 2001 to 2006. There were still patients receiving hydroxyurea and IFN-alpha. As the first-line regime for CML, imatinib was less administered in Shanghai before, but has received considerable development and great responses since 2003. (Source: Journal of Experimental and Clinical Cancer Research)
More